In an increasingly data-driven world, artificial intelligence is expected to be a key tool for
converting big data into tangible benefits and the healthcare domain is no exception to this …

Background and Motivation: Diagnosis of Parkinson's disease (PD) is often based on
medical attention and clinical signs. It is subjective and does not have a good prognosis …

Objectives Mild behavioral impairment (MBI) is a syndrome describing late-onset persistent
neuropsychiatric symptoms (NPS) in non-demented older adults. Few studies to date have …

Background and Objectives Mild cognitive impairment (MCI) is an at-risk state for dementia;
however, not all individuals with MCI transition to dementia, and some revert to normal …

Background: Mild behavioral impairment (MBI) and subjective cognitive decline (SCD) are
dementia risk states, and potentially represent neurobehavioral and neurocognitive …

Objective To compare the utility of the Mild Behavioral Impairment-Checklist (MBI-C) and
Neuropsychiatric Inventory Questionnaire (NPI-Q) to capture NPS in subjective cognitive …

Background Disease-modifying drug use necessitates better Alzheimer disease (AD)
detection. Mild cognitive impairment (MCI) leverages cognitive decline to identify the risk …

Background: The International Psychogeriatric Association (IPA) published a provisional
consensus definition of agitation in cognitive disorders in 2015. As proposed by the original …

Introduction: Simple markers are required to recognize older adults at higher risk for
neurodegenerative disease. Mild behavioural impairment (MBI) and plasma β-amyloid (Aβ) …

Background and Objectives Plasma phosphorylated tau at threonine 181 (p-tau181), a well-
validated marker of Alzheimer disease (AD) pathologic change, could be a more efficient …